Author:
BREARLEY S.G.,CRAVEN O.,SAUNDERS M.,SWINDELL R.,MOLASSIOTIS A.
Reference20 articles.
1. A changing paradigm for cancer treatment: the advent of new oral chemotherapy agents;Bedell;Clinical Journal of Oncology Nursing,2003
2. Oral chemotherapy: progress with challenges;Bedell;Hematology Oncology News and Issues,2002
3. First-line oral capecitabine therapy in metastatic colorectal cancer: a favorable safety profile compared with intravenous 5-fluorouracil/leucovorin;Cassidy;Annals of Oncology,2002
4. European Medicines Agency (EMEA) 2005 Scientific discussion http://www.emea.europa.eu/humandocs/PDFs/EPAR/Xeloda/282200en6.pdf
5. European Medicines Agency (EMEA) 2008 Annex 1: Summary of product characteristics http://www.emea.europa.eu/humandocs/PDFs/EPAR/Xeloda/H-316-PI-en.pdf
Cited by
7 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献